Gould Capital, LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 242 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
Gould Capital, LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$13,145
+18.2%
5000.0%0.01%
+22.2%
Q2 2023$11,125
+2.7%
5000.0%0.01%
+12.5%
Q1 2023$10,830
+6.6%
5000.0%0.01%0.0%
Q4 2022$10,155
-21.9%
5000.0%0.01%
-27.3%
Q3 2022$13,000
+8.3%
5000.0%0.01%
+10.0%
Q2 2022$12,000
+9.1%
5000.0%0.01%
+25.0%
Q1 2022$11,000
+10.0%
5000.0%0.01%
+14.3%
Q4 2021$10,0005000.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,370,017$181,2959.31%
Novo Holdings A/S 3,377,768$73,162,4554.83%
Parallel Advisors, LLC 3,724,573$80,674,2512.72%
TANAKA CAPITAL MANAGEMENT INC 35,539$7702.24%
Shay Capital LLC 350,000$7,581,0001.49%
Shay Capital LLC 350,000$7,581,0001.49%
S&T BANK/PA 350,924$7,6011.37%
Birchview Capital, LP 50,000$1,0830.85%
Clearview Wealth Advisors LLC 34,275$742,3970.75%
Granite Investment Partners, LLC 795,076$17,221,3460.72%
View complete list of CORCEPT THERAPEUTICS INC shareholders